Intracranial hypertension with severe and irreversible reduced acuity and impaired visual fields after oral tetracycline;Intracraniële hypertensie met ernstige en blijvende visusdaling en gezichtsvelduitval na gebruik van orale tetracycline

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 34, 2005, Pages 1908-1912

  Altinbas, A ^a,b   Hoogstede, H A L F ^a   Bakker, S L M ^a  

^a AMPHIA HOSPITAL   (Netherlands)

^b Ziekenhuis Hilversum   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; TETRACYCLINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; FENESTRATION; HEADACHE; HUMAN; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; NEUROOPHTHALMOLOGY; OPHTHALMOSCOPY; OPTIC NERVE; PAPILLEDEMA; PERIMETRY; SHUNTING; VISUAL ACUITY; VISUAL FIELD DEFECT;

ACETAZOLAMIDE; ADMINISTRATION, ORAL; ADULT; DIURETICS; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; PAPILLEDEMA; RECURRENCE; SPINAL PUNCTURE; TETRACYCLINE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELDS;

EID: 23944502243     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hoefnagel JJ, Leeuwen RL van, Mattie H, Bastiaens MT. Bijwerkingen van minocycline in de behandeling van acne vulgaris. Ned Tijdschr Geneeskd 1997;141:1424-7.
2. Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001;21:12-4.
3. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004;63:1737-9.
4. Mathews MK, Sergott RC, Savino PJ. Pseudotumor cerebri. Curr Opin Ophthalmol 2003;14:364-70.
5. Intracranial hypertension, unexpected complication of treatments with tetracycline in infants [French]. Presse Med 1961;69:1231.
6. Maroon JC, Mealy jr J. Benign intracranial hypertension. Sequel to tetracycline therapy in a child. JAMA 1971;216:1479-80.
7. Weese-Mayer DE, Yang RJ, Mayer JR, Zaparackas Z. Minocycline and pseudotumor cerebri: the well-known but well-kept secret. Pediatrics 2001;108:519-20.
8. Lochhead J, Elston JS. Doxycycline induced intracranial hypertension. BMJ 2003;326:641-2.
9. Kuipers F. Pseudotumor cerebri door tetracycline. Ned Tijdschr Geneeskd 1971;115:2070.
10. Heide RM van der. Pseudotumor cerebri door tetracycline. Ned Tijdschr Geneeskd 1990;134:1423-4.
11. Cellucci T, Lee L, Juurlink DN. The headache of teenage acne. CMAJ 2004;170:1788-9.
12. Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clin Proc 1994;69:169-80.
13. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492-5.
14. Walker RWH. Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure? J Neurol Neurosurg Psychiatry 2001;71:1-5.
15. King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002;58:26-30.
16. Chiu AM, Chuenkongkaew WL, Cornblath WT, Trobe JD, Digre KB, Dotan SA, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998;126:116-21.
17. Pagan FI, Restrepo L, Balish M, Patwa HS, Houff S. A new drug for an old condition? Headache 2002;42:695-6.
18. Palacio E, Rodero L, Pascual J. Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndrome. Headache 2O04;44:436-7.
19. Johnson LN, Krohel GB, Madsen RW, March jr GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998; 105:2313-7.
20. Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982;39:461-74.
21. Digre KB. Not so benign intracranial hypertension. BMJ 2003;326:613-4.